Clik here to view.
How New Sequencing Technologies Are Unravelling Rare Genetic Diseases
Cross-posted (in a slimmed-down form) on the Wellcome Trust blog. Rare diseases matter There are thousands of rare genetic diseases, ranging from the widely-known (such as Huntington’s disease, an...
View ArticleClik here to view.
23andMe Releases Results For Major Alzheimer’s Risk Marker
Some important news this morning in the consumer genetics space: personal genomics company 23andMe has just announced the availability of risk information for Alzheimer’s disease using two markers in...
View ArticleClik here to view.
Advantages of the Genome Factory
A couple of weeks ago I blogged about my visit to Mountain View-based Complete Genomics, a DNA sequencing company with a novel service-based approach (rather than selling sequencing instruments they...
View ArticleClik here to view.
Last chance: let the FDA know why you want direct access to your own genome
Regular readers of this blog will be very familiar with the fledgling personal genomics industry, a diverse set of companies offering to sell you information about your ancestry and disease risk based...
View ArticleMy submission to the FDA on the regulation of personal genomics
I noted last week the opportunity for public submissions to the FDA on the regulation of personal genomics (sadly, the deadline for submission has now passed). I put together my own submission over the...
View ArticleClik here to view.
Yet another trial by press release for personal genomics
Typical consumer response to seeing their own genome sequence.A press release launched yesterday by the European Society of Human Genetics announces two upcoming presentations at the Society’s annual...
View ArticleClik here to view.
How accurate is the new Ion Torrent genome, really?
New sequencing technology Ion Torrent has made a splash with a paper in today’s issue of Nature. There’s no question the high-impact publication is a massive boost for the young platform, now nestled...
View ArticleClik here to view.
Longevity genetics study retracted from Science
In July last year I wrote about some fairly glaring flaws in a paper published in Science on the genetics of extreme longevity. At the time, potential problems with the paper had been flagged in an...
View ArticleClik here to view.
Personal genomics: no longer just for white folks
Note: I removed the word “rich” from the title following comments below about potential misinterpretation This morning personal genomics company 23andMe launched an initiative designed to shift the...
View ArticleClik here to view.
Will Prenatal Screening for Serious Diseases Rob Us of Our Creativity?
David Goldstein has a commentary in this week’s issue of Nature on the potential impact of prenatal genetic screening on society (subscription required, unfortunately). The major issues it raises...
View ArticleClik here to view.
Welcome to the new Genetic Future
Well, here we are: the shiny new home of Genetic Future here at Wired. I’m excited to be joining the frankly intimidatingly talented blogging team here, and looking forward to seriously blogging again...
View ArticleClik here to view.
On sharing genes with friends
A PNAS paper published on Monday grabbed plenty of headlines (my favorite being “Best friends forever gene: It’s all in our DNA, say scientists” from the ever-reliable Daily Mail). Presumably that’s...
View ArticleGuest Post: Introduction to Nanopore Sequencing
[Advances in DNA sequencing are crucial for the future of personal genomics, and approaches based on nanopores - tiny holes in a solid matrix, which can detect molecules passing through them - are a...
View ArticleClik here to view.
Should you trust a direct-to-consumer genetic test?
While I’m travelling over the next two weeks I’m dusting off some posts from the archives. This is an expanded, updated version of a post as I wrote on Genomes Unzipped as my contribution to Mary...
View ArticleClik here to view.
Plug And Play For DNA
In the fast-paced world of DNA sequencing technology, Oxford Nanopore Technologies provides a touch of tasteful British reserve in a sea of Californian brashness. While the likes of Pacific Biosciences...
View ArticleGot to Give It Up
By guest author Misha Angrist. Genetic Future will be back to more regular posting next week, when I get back from holiday. In the meantime I asked the one and only Misha Angrist – Assistant Professor,...
View ArticleClik here to view.
One database to hold them all
The unravelling of the human genome and subsequent advances in genetic technology have had a profound effect on our understanding of the genetics of severe, rare diseases. The genetic map provided by...
View ArticleClik here to view.
Getting Our Act Together for the Second Decade of Human Genomics
By guest author Dan Vorhaus. Many readers will have seen the new strategic plan from the National Human Genome Research Institute (NHGRI), published last week in Nature. This is a document of ambitious...
View ArticleClik here to view.
When Is A Strategic Plan Not A Strategic Plan?
The National Human Genome Research Institute (NHGRI) organised a “bloggers-only” conference call last night with director Eric Green to discuss the Institute’s new strategic plan (published in Nature...
View ArticleWhen “Cautious” Means “Useless”
This is something that has been bugging me for a while, and I have to get it off my chest. Last week the Coriell Personalized Medicine Coalition announced a partnership with Ohio State University to...
View Article
